Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials

JAMA

Volumn 293, Issue 24, 2005, Pages 3043-3052

  Eisenberg, Elon ^a,b   McNicol, Ewan D ^c   Carr, Daniel B ^c,d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Innovative Drug Delivery Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BENZATROPINE; CARBAMAZEPINE; CODEINE; DESIPRAMINE; DIPHENHYDRAMINE; FENTANYL; KETAMINE; METHADONE; MORPHINE; NORTRIPTYLINE; OPIATE AGONIST; OXYCODONE; PETHIDINE; NARCOTIC ANALGESIC AGENT;

CLINICAL TRIAL; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEDLINE; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; UNITED STATES; VOMITING; CONTROLLED CLINICAL TRIAL; INTRACTABLE PAIN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

ANALGESICS, OPIOID; HUMANS; PAIN, INTRACTABLE; RANDOMIZED CONTROLLED TRIALS;

EID: 20644431597     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.293.24.3043     Document Type: Review

References (53)

1. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med. 2003;348:1279-1281.
2. Yarnitsky D, Eisenberg E. Neuropathic pain: between positive and negative ends. Pain Forum. 1998;7:241-242.
3. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389-400.
4. McQuay HJ. Opioid use in chronic pain. Acta Anaesthesiol Scand. 1997;41:175-183.
5. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 1999;80:453-462.
6. Canavero S, Bonicalzi V. Chronic neuropathic pain. N Engl J Med. 2003;348:2688-2689.
7. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
8. Nicholson BD. Evaluation and treatment of central pain syndromes. Neurology. 2004;62(suppl 2):S30-S36.
9. Carver A, Foley K. Facts and an open mind should guide clinical practice. Curr Neurol Neurosci Rep. 2001;1:97-98.
10. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2004;2:CD003726.
11. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
12. Clarke M, Oxman AD, eds. Analysing and Presenting Results: Cochrane Reviewers' Handbook 4.2 [updated November 2002]. Section 8. In: The Cochrane Library [database on disk and CD-ROM]. Oxford: Update Software; 2003:issue 1.
13. Jorum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine: a double-blind, cross-over comparison with alfentanil and placebo. Pain. 2003;101:229-235.
14. Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D. Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology. 2002;58:554-563.
15. Wu CL, Tella P, Staats PS, et al. Analgesic effects of intravenous lidocaine and morphine on postamputation pain: a randomized double-blind, active placebo-controlled, crossover trial. Anesthesiology. 2002;96:841-848.
16. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 2001;91:177-187.
17. Rabben T, Skjelbred P, Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 1999;289:1060-1066.
18. Dellemijn PL, Vanneste JA. Randomised doubleblind active-placebo- controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 1997;349:753-758.
19. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol. 1995;18:360-368.
20. Eide PK, Stubhaug A, Stenehjem AE. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery. 1995;37:1080-1087.
21. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347-354.
22. Jadad AR, Carroll D, Glynn CJ, Moore RA, McQuay HJ. Morphine responsiveness of chronic pain: doubleblind randomised crossover study with patientcontrolled analgesia. Lancet. 1992;339:1367-1371.
23. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
24. Kupers RC, Konings H, Adriaensen H, Gybels JM. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain. 1991;47:5-12.
25. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988;33:11-23.
26. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther. 1988;43:363-371.
27. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841.
28. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain. 2001;90:47-55.
29. Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a doubleblinded randomized study. Anesth Analg. 2001;92:488-495.
30. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59:1015-1021.
31. Gimbel JS, Richards P, Portenoy RK. Controlledrelease oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60:927-934.
32. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71-78.
33. Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med. 2003;17:576-587.
34. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med. 2003;348:1223-1232.
35. Maier C, Hildebrandt J, Klinger R, Henrich-Eberl C, Lindena G; MONTAS Study Group. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain: results of a doubleblind placebo-controlled trial (MONTAS). Pain. 2002;97:223-233.
36. Kalman S, Osterberg A, Sorensen J, Boivie J, Bertler A. Morphine responsiveness in a group of welldefined multiple sclerosis patients: a study with i.v. morphine. Eur J Pain. 2002;6:69-80.
37. Benedetti F, Vighetti S, Amanzio M, et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain. 1998;74:205-211.
38. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452-454.
39. Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JP, Lau J. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr. 2004;32:23-31.
40. Stanton-Hicks MD, Burton AW, Bruehl SP, et al. An updated interdisciplinary clinical pathway for CRPS: report of an expert panel. Pain Pract. 2002;2:1-16.
41. McNicol E, Strassels S, Goudas L, Lau J, Carr D. Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J Clin Oncol. 2004;22:1975-1992.
42. Mailis A, Furlan A. Sympathectomy for neuropathic pain. Cochrane Database Syst Rev. 2003;2:CD002918.
43. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831-1836.
44. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000;88:287-294.
45. Cepeda MS, Africano JM, Polo R, Alcala R, Carr DB. What decline in pain intensity is meaningful to patients with acute pain? Pain. 2003;105:151-157.
46. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
47. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Symptom Manage. 1996;12:161-167.
48. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D. Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology. 2004;62:218-225.
49. Cohen SP, Chang AS, Larkin T, Mao J. The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesth Analg. 2004;99:1753-1759.
50. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4:231-256.
51. Sullivan M, Ferrell B. Ethical challenges in the management of chronic nonmalignant pain: negotiating through the cloud of doubt. J Pain. 2005;6:2-9.
52. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11:163-171.
53. Wittick H, Carr DB, eds. Pain Management: Evidence, Outcomes and Quality of Life: A Sourcebook. Amsterdam, the Netherlands: Elsevier; 2005.